Specialty Pharma Journal Specialty, Precision & Technology
Roche’s Ventana Medical Systems has inked a deal with Astellas Pharma aimed at developing new diagnostic tests for targeted cancer treatments. The cancer diagnostics company announced that it has entered into master collaboration agreement with Astellas Pharma to develop novel automated tissue diagnostics in support of therapeutic compounds in development. …
Tag Archives: Companion diagnostics tests
April, 2015
-
1 April
Myriad and AstraZeneca Expand Companion Diagnostic Collaboration into Lynparza Study in Pancreatic Cancer Patients
Myriad Genetics, Inc. and AstraZeneca have expanded their companion diagnostic collaboration to include the utilization of Myriad’s diagnostic test to identify best responders to AstraZeneca’s investigational pancreatic cancer drug. The companies said that under the terms of the expanded agreement, Myriad’s BRACAnalysis CDx test will be used prospectively to identify …
March, 2015
-
19 March
Myriad Expands Collaboration with BioMarin for Cancer Companion Diagnostic Test
Myriad Genetics recently announced that it has expanded its collaboration with BioMarin Pharmaceutical to use Myriad’s myChoice HRD companion diagnostic test. Under the deal, BioMarin will use Myriad’s myChoice HRD companion diagnostic test to prospectively identify patients with metastatic breast, ovarian and potentially other tumor types that may be sensitive …